Propensity score-incorporated adaptive design approaches when incorporating real-world data

被引:0
|
作者
Lu, Nelson [1 ]
Chen, Wei-Chen [1 ]
Li, Heng [1 ]
Song, Changhong [1 ]
Tiwari, Ram [2 ]
Wang, Chenguang [3 ,4 ]
Xu, Yunling [1 ]
Yue, Lilly Q. [1 ,5 ]
机构
[1] US FDA, Div Biostat, Ctr Devices & Radiol Hlth, Silver Spring, MD USA
[2] Bristol Myers Squibb, Global Biometr & Data Sci, Lawrence, NJ USA
[3] Johns Hopkins Univ, Sidney Kimmel Comprehens Canc Ctr, Div Biostat & Bioinformat, Baltimore, MD USA
[4] Regeneron Pharmaceut, Tarrytown, NY USA
[5] US FDA, Div Biostat, Ctr Devices & Radiol Hlth, 10903 New Hampshire Ave, Silver Spring, MD 20993 USA
关键词
adaptive design; composite likelihood; Cui-Hung-Wang test; Fisher's combination test; outcome-free design; propensity score; PSCL; real-world data; real-world evidence; RWD; RWE; CAUSAL INFERENCE; TRIAL;
D O I
10.1002/pst.2347
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The propensity score-integrated composite likelihood (PSCL) method is one method that can be utilized to design and analyze an application when real-world data (RWD) are leveraged to augment a prospectively designed clinical study. In the PSCL, strata are formed based on propensity scores (PS) such that similar subjects in terms of the baseline covariates from both the current study and RWD sources are placed in the same stratum, and then composite likelihood method is applied to down-weight the information from the RWD. While PSCL was originally proposed for a fixed design, it can be extended to be applied under an adaptive design framework with the purpose to either potentially claim an early success or to re-estimate the sample size. In this paper, a general strategy is proposed due to the feature of PSCL. For the possibility of claiming early success, Fisher's combination test is utilized. When the purpose is to re-estimate the sample size, the proposed procedure is based on the test proposed by Cui, Hung, and Wang. The implementation of these two procedures is demonstrated via an example.
引用
收藏
页码:204 / 218
页数:15
相关论文
共 50 条
  • [1] Incorporating external real-world data (RWD) in confirmatory adaptive design
    Lin, Junjing
    Lin, Jianchang
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2024, 34 (06) : 805 - 817
  • [2] Propensity-score-based meta-analytic predictive prior for incorporating real-world and historical data
    Liu, Meizi
    Bunn, Veronica
    Hupf, Bradley
    Lin, Junjing
    Lin, Jianchang
    STATISTICS IN MEDICINE, 2021, 40 (22) : 4794 - 4808
  • [3] Endometriosis and endometrial cancer: A propensity score-adjusted real-world data study
    Farolfi, Alberto
    Gentili, Nicola
    Testoni, Sara
    Rusconi, Francesca
    Massa, Ilaria
    Danesi, Valentina
    Altavilla, Amelia
    Cursano, Maria C.
    Gurioli, Giorgia
    Burgio, Salvatore L.
    Ibarburu, Gema Hernandez
    Giorgi, Ugo De
    ISCIENCE, 2024, 27 (05)
  • [4] When can real-world data generate real-world evidence?
    Rahman, Motiur
    Dal Pan, Gerald
    Stein, Peter
    Levenson, Mark
    Kraus, Stefanie
    Chakravarty, Aloka
    Rivera, Donna R.
    Forshee, Richard
    Concato, John
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2024, 33 (01)
  • [5] Propensity score-integrated composite likelihood approach for augmenting the control arm of a randomized controlled trial by incorporating real-world data
    Chen, Wei-Chen
    Wang, Chenguang
    Li, Heng
    Lu, Nelson
    Tiwari, Ram
    Xu, Yunling
    Yue, Lilly Q.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (03) : 508 - 520
  • [6] Practical considerations of utilizing propensity score methods in clinical development using real-world and historical data
    Li, Qing
    Lin, Jianchang
    Chi, Andy
    Davies, Simon
    CONTEMPORARY CLINICAL TRIALS, 2020, 97
  • [7] Evaluating large-scale propensity score performance through real-world and synthetic data experiments
    Tian, Yuxi
    Schuemie, Martijn J.
    Suchard, Marc A.
    INTERNATIONAL JOURNAL OF EPIDEMIOLOGY, 2018, 47 (06) : 2005 - 2014
  • [8] Ocrelizumab and ofatumumab comparison: an Italian real-world propensity score matched study
    Zanghi, Aurora
    Borriello, Giovanna
    Bonavita, Simona
    Fantozzi, Roberta
    Signoriello, Elisabetta
    Barone, Stefania
    Abbadessa, Gianmarco
    Cellerino, Maria
    Ziccone, Vanessa
    Miele, Giuseppina
    Lus, Giacomo
    Valentino, Paola
    Bucello, Sebastiano
    Inglese, Matilde
    Centonze, Diego
    Avolio, Carlo
    D'Amico, Emanuele
    JOURNAL OF NEUROLOGY, 2024, 271 (07) : 4495 - 4502
  • [9] Propensity score-integrated power prior approach for incorporating real-world evidence in single-arm clinical studies
    Wang, Chenguang
    Li, Heng
    Chen, Wei-Chen
    Lu, Nelson
    Tiwari, Ram
    Xu, Yunling
    Yue, Lilly Q.
    JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2019, 29 (05) : 731 - 748
  • [10] Differences Between Conditional and Marginal Propensity Score Estimates A Real-World Application
    Samuel, Michelle
    Schuster, Tibor
    Kaufman, Jay S.
    Platt, Robert W.
    Brophy, James M.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 70 (01) : 117 - 117